e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Animal models of pulmonary fibrosis: mechanisms and therapies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alveolar extracellular 20S proteasome in patients with acute respiratory distress syndrome
S. Sixt, J. Hakenbeck, M. Adamzik, D. Spyrka, B. Saul, B. Dahlmann, J. Peters (Essen, Berlin, Germany)
Source:
Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Session:
Animal models of pulmonary fibrosis: mechanisms and therapies
Session type:
Thematic Poster Session
Number:
720
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Sixt, J. Hakenbeck, M. Adamzik, D. Spyrka, B. Saul, B. Dahlmann, J. Peters (Essen, Berlin, Germany). Alveolar extracellular 20S proteasome in patients with acute respiratory distress syndrome. Eur Respir J 2008; 32: Suppl. 52, 720
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Related content which might interest you:
Exogenous pulmonary surfactant combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome
Source: Annual Congress 2007 - Lung recruitment
Year: 2007
Surfactant metabolism and replacement in acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=119
Year: 2002
Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006
Alpha1-antitrypsin (α1-AT) and secretory leukocyte protease inhibitor (SLPI) in acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in critically ill infants
Source: Annual Congress 2008 - Respiratory disorders in paediatric intensive care unit
Year: 2008
Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
TGF-β inhibits alveolar fluid reabsorption: a role in ARDS?
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
Exogenous surfactant in acute respiratory distress syndrome: more is better
Source: Eur Respir J 2002; 19: 787-789
Year: 2002
Phenotypes of acute respiratory distress syndrome
Source: Virtual Congress 2021 – Respiratory critical care
Year: 2021
Proteinomics and ARDS
Source: Annual Congress 2007 - Acute respiratory distress syndrome: from basic science to bedside
Year: 2007
Alveolar lymphocyte phenotype and respiratory distress syndrome
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Corticosteroids in acute respiratory distress syndrome
Source: Virtual Congress 2021 – Respiratory critical care
Year: 2021
Corticosteroids and acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007
Pneumonectomy subjects with acute respiratory distress syndrome: what to do
Source: Eur Respir Rev 2015; 24: 154
Year: 2015
Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients
Source: Eur Respir J, 56 (5) 2001531; 10.1183/13993003.01531-2020
Year: 2020
Pulmonary gas-exchange impairments in pulmonary diseases: mechanisms
Source: Annual Congress 2007 - PG2 - Respiratory physiology: pulmonary gas transfer and arterial blood gases
Year: 2007
Characterization of small airways structural alterations in acute respiratory distress syndrome
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
The impact of two partial ventilatory support modalities on lung histology and inflammatory mediators in a model of acute respiratory distress syndrome
Source: Annual Congress 2007 - Acute lung injury and inflammation
Year: 2007
Role of heat shock proteins in the lungs of acute lung injury
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006
Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome
Source: Eur Respir J 2003; 21: 720-727
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept